KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Shares Issued (2016 - 2025)

Astrana Health (ASTH) has disclosed Shares Issued for 11 consecutive years, with $301000.0 as the latest value for Q1 2025.

  • Quarterly Shares Issued changed N/A to $301000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2025, up 184.48% year-over-year, with the annual reading at $755000.0 for FY2024, N/A changed from the prior year.
  • Shares Issued hit $301000.0 in Q1 2025 for Astrana Health, down from $523000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $35.9 million in Q2 2021 to a low of -$33.5 million in Q3 2021.
  • Historically, Shares Issued has averaged $778230.8 across 5 years, with a median of $523000.0 in 2024.
  • Biggest YoY gain for Shares Issued was 1558.71% in 2021; the steepest drop was 1009.0% in 2021.
  • Year by year, Shares Issued stood at $2.5 million in 2021, then crashed by 213.17% to -$2.8 million in 2022, then soared by 55.1% to -$1.2 million in 2023, then surged by 141.84% to $523000.0 in 2024, then tumbled by 42.45% to $301000.0 in 2025.
  • Business Quant data shows Shares Issued for ASTH at $301000.0 in Q1 2025, $523000.0 in Q4 2024, and $232000.0 in Q3 2024.